Tubulis has completed a Series C, securing €308m ($361m) to be directed towards advancing clinical development of its ADC ...
Cancer is no longer a rare disease in India. Each year, more than 14 lakh people are diagnosed, and many reach hospitals only ...
A cervical cancer survivor addresses slow progress on health reforms, highlighting gaps in gynaecological cancer care in ...
The sale of baby powder containing talc stopped in the UK in 2023. The UK action mirrors extensive litigation in the US, ...
German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round ...
Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) jumped 7.7% in the afternoon session after it submitted a ...
When doctors told the father of two his cancer was seen just three times a year in Oregon, he found a lifeline 2,000 miles ...
Uterine cancer symptoms include irregular bleeding and pelvic pain, but early diagnosis through medical evaluation can lead ...
Corcept files a marketing application with the EMA for relacorilant in platinum-resistant ovarian cancer after studies show survival gains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback